)
Cardinal Health (CAH) investor relations material
Cardinal Health Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Fiscal 2026 delivered strong operational and financial results, with double-digit profit growth across all five operating segments and significant progress on strategic priorities, including expansion in Specialty, targeted acquisitions, and operational excellence initiatives.
The Board oversaw capital allocation, risk management, and succession planning, including the transition to a new independent Chair and several committee leadership changes to align expertise with evolving oversight needs.
Governance practices were further strengthened, with enhanced integration of enterprise risk management and active shareholder engagement representing 26% of outstanding shares.
The company enters fiscal 2027 with strong momentum, a confident leadership team, and a focus on sustainable long-term value creation.
Voting matters and shareholder proposals
Shareholders are asked to elect 11 director nominees, approve (advisory) executive compensation, and ratify Ernst & Young LLP as independent auditor for fiscal 2027.
The Board recommends voting FOR all proposals.
Shareholders may submit proposals and director nominations for the 2027 annual meeting, with proxy access provisions allowing groups holding 3%+ of shares for 3 years to nominate directors.
Board of directors and corporate governance
The Board consists of 11 nominees with diverse backgrounds, 91% independence, 45% women, and 27% racially/ethnically diverse.
Leadership structure includes an independent Chair, separate CEO, and independent committee chairs.
Four standing committees: Audit, Governance and Sustainability, Human Resources and Compensation, and Risk Oversight, all composed of independent directors.
Ongoing board refreshment, succession planning, and comprehensive director orientation and education are emphasized.
Annual board and committee self-evaluations are conducted, with action plans developed in response to feedback.
- Double-digit growth across all segments, with specialty and acquisitions driving future strategy.CAH
2026 Global Healthcare Conference - Virtual meeting to vote on directors, executive pay, and auditor ratification for 2026.CAH
Proxy filing - Guidance targets 13%-15% EPS growth in 2027, led by specialty and pharma investments.CAH
Morgan Stanley 24th Annual Global Healthcare Conference - Specialty and generics growth, strategic M&A, and disciplined investment drive strong outlook.CAH
Wells Fargo 21st Annual Healthcare Conference - Strong FY26 results, double-digit profit growth, and robust FY27 EPS guidance.CAH
Q4 2026 - Double-digit growth, innovation, and disciplined investment drive a strong outlook for the year.CAH
Evercore ISI 8th Annual HealthCONx Conference - Profit growth, raised guidance, and strategic M&A drive momentum and long-term resilience.CAH
Bank of America Global Healthcare Conference 2026 - Specialty and diversified segments drive robust growth, with $10B+ cash flow expected.CAH
Baird Global Healthcare Conference 2025 - Record FY24 results and raised FY25 guidance signal strong profit growth ahead.CAH
Q4 2024
Next Cardinal Health earnings date
Next Cardinal Health earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
Frequently asked questions
Major Provider of Medical Products
Cardinal Health, Inc. Is an American healthcare services company with multinational operations. It specializes in the distribution of pharmaceuticals and medical products, delivering to over 100,000 different locations across the globe. Besides its distribution, it also manufactures various medical products and equipment used in surgeries. It supplies a large majority of hospitals in the US and is headquartered in Dublin, Ohio. Its shares are traded on the NYSE.
Starting Out in Food Distribution
Cardinal Health was founded in 1971 by Robert D. Walter. Originally established as Cardinal Foods, it began as a food distribution business. However, in the early 1980s, the company transitioned into pharmaceutical distribution. Over the subsequent years, Cardinal Health broadened its reach and services through a combination of organic growth, innovation, and acquisitions.
Operations
Its core operation lies in the distribution of pharmaceuticals and medical products. The company facilitates the delivery of medications and related services to various healthcare providers, including hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. Beyond pharmaceutical distribution, Cardinal Health is also involved in the sale of generic pharmaceuticals, over-the-counter medications, and consumer health products. A specialized branch within the company deals with nuclear pharmacy services, which involve the preparation and delivery of patient-specific doses of radiopharmaceuticals. When looking at the company’s peers, one finds names such as McKesson, Becton, Dickinson and Company, and Owens & Minor.
Surgical Equipment
In terms of surgical science equipment, the company offers a variety of items that cater to different clinical needs. These products range from basic consumables, such as surgical drapes, gowns, and gloves, to more specialized equipment used in surgical settings. They also provide fluid management systems, wound care products, and sterilization wraps. While the company does not manufacture all these products in-house, it partners with manufacturers to ensure a comprehensive product offering for healthcare institutions.
)